LONDON (Reuters) - The line between pharmaceuticals and technology is blurring as companies join forces to tackle chronic diseases using high-tech devices that combine biology, software and hardware.
from Reuters: Technology News http://ift.tt/2apZfwD
No comments:
Post a Comment